Shuttle Pharmaceuticals Holdings (SHPH) Current Assets (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Current Assets came in at $2.5 million in Q1 2026, down 50.34% year-on-year from $5.0 million in Q1 2025, and up 389.74% quarter-over-quarter from $502911.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Current Assets (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Current Assets history runs 6 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- On a quarterly basis, Current Assets fell 50.34% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 50.34% decrease from a year earlier, with the FY2025 full-year figure at $502911.0, down 77.25% from the prior year.
- Current Assets advanced to $2.5 million in Q1 2026 per SHPH's latest filing, from $502911.0 in the prior quarter.
- Across five years, Current Assets topped out at $10.4 million in Q1 2023 and bottomed at $361351.0 in Q3 2024.
- The 5-year median for Current Assets is $5.0 million (2025), against an average of $5.0 million.
- Across the five-year window, Current Assets surged 1583.3% in 2022 and plunged 94.83% in 2024, its largest moves.
- Year by year, Current Assets stood at $8.6 million in 2022, then sank by 34.8% to $5.6 million in 2023, then plunged by 60.47% to $2.2 million in 2024, then sank by 77.25% to $502911.0 in 2025, then jumped by 389.74% to $2.5 million in 2026.
- Per Business Quant, the three latest SHPH Current Assets figures stand at $2.5 million (Q1 2026), $502911.0 (Q4 2025), and $3.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | 2.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.46 Mn |
| Dec 31, 2025 | 502,911.00 |
| Sep 30, 2025 | 3.27 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | 4.96 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 361,351.00 |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 4.41 Mn |
| Dec 31, 2023 | 5.59 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Jun 30, 2023 | 8.44 Mn |
| Mar 31, 2023 | 10.37 Mn |
| Dec 31, 2022 | 8.58 Mn |
| Sep 30, 2022 | 9.29 Mn |
| Dec 31, 2021 | 509,615.00 |